Composite hemostatic fabric and preparation method thereof
By combining long-chain polysaccharides, glycerol, bovine thrombin and bovine serum albumin with inorganic hemostatic agents, forming a fishnet structure to load it on the fiber surface, solving the problems of high energy consumption, high cost and shedding rate of existing hemostatic materials, achieving high efficiency, Low-risk hemostatic effect.
Patent Information
- Application Number
- CN202411028528.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-30
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-30
AI Technical Summary
The existing hemostatic materials are used in high temperature and high pressure during the production process, have high energy consumption, high cost and unfriendly environment, and cannot effectively stop bleeding in patients with coagulation dysfunction and deep bleeding. The inorganic hemostatic agent has a high shedding rate and a high potential clinical risk. .
The composite hemostatic fabric that combines long-chain polysaccharides, glycerin, bovine thrombin and bovine serum albumin with inorganic hemostatic agent is uniformly loaded on the fiber surface by high-speed stirring and mechanical device to form a fishing net structure to improve the hemostatic effect, and Stabilize inorganic hemostatic agents through protein adsorption.
It achieves a hemostatic effect with low energy consumption, low cost and low shedding rate, which can effectively stop bleeding in patients with coagulation dysfunction and deep bleeding, reduces clinical risks, and has a soft feel and is suitable for use in complex environments.
Smart Images

Figure CN118949112A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of hemostatic fabrics, in particular to a composite hemostatic fabric and a preparation method thereof. Background Art
[0002] Among the causes of death in traffic accidents, wars and major natural disasters, uncontrollable massive bleeding is one of the main causes. Since the coagulation system of the human body or animal itself requires a relatively slow activation process, it cannot solve large-scale and rapid bleeding such as arterial bleeding, resulting in nearly half of the deaths occurring in the pre-hospital stage. In some cases, the trauma and bleeding are mild, and in addition to simple first aid, only conventional coagulation function is required to stop bleeding normally. It is worth noting that for patients with coagulation dysfunction, even if bleeding from a small wound cannot be stopped by conventional hemostasis methods, and in severe cases, the bleeding does not stop and endangers life. In modern warfare, with the widespread use of rotary tourniquets, the probability of death of the wounded due to massive bleeding in the limbs has been greatly reduced. However, due to the lack of effective means, bleeding that cannot be controlled by tourniquets in the chest, abdomen, head, neck, and junctions is often accompanied by rupture of the aorta, leading to massive bleeding, and it is easy to cause the death of the wounded due to untimely or unsatisfactory hemostasis; this type of war wound bleeding has become the primary factor in fatal massive bleeding deaths in modern warfare. Because the bleeding site between the trunk and the junction is deep, it is often difficult to use clamps to stop bleeding for emergency treatment on the battlefield, and it is difficult to stop bleeding, which has become a difficult point in the treatment of war injuries. If the treatment of massive bleeding is not timely, excessive blood loss may occur, and death from bleeding is a very serious global problem; the World Health Organization reports that 1.9 million people die from excessive bleeding every year worldwide. Therefore, in the emergency treatment of sudden accidents in daily life, the hemostasis of trauma during surgery in hospitals, and especially the rescue of wounded soldiers in war, it is very important to stop bleeding effectively and quickly for patients. Therefore, the development of safe, effective, fast, portable, and low-cost pre-hospital hemostatic agents, while also meeting the hemostatic materials used by patients with coagulation function to stop bleeding, has always been an urgent need for emergency hemostasis.
[0003] At present, commercialized topical hemostatic products can be roughly divided into the following six categories according to raw materials:
[0004] 1. Fibrin glue: The main functional components of this type of product are fibrinogen and thrombin. Fibrin glue-type hemostatic materials are expensive and have harsh storage conditions, making them unsuitable for use outside hospitals.
[0005] 2. Gelatin and collagen, the prices of these products are also relatively high;
[0006] 3. Polysaccharide hemostatic agents, such as alginate, chitosan and starch;
[0007] 4. Artificially synthesized polymer materials, such as cyanoacrylate, polyethylene glycol, polyglycolic acid and polyacrylic acid, are all polymer hemostatic materials;
[0008] 5. Inorganic hemostatic agents, including natural or synthetic zeolite, kaolin, montmorillonite, etc.;
[0009] 6. Cellulose materials: As the earliest wound dressing and hemostatic materials, cotton bandages or gauze are accepted by people because of their convenience, ease of use and good biocompatibility, but their hemostatic effect is not good.
[0010] A large number of animal experiments and clinical trials have proved that among the above six hemostatic materials, inorganic hemostatic agents and polysaccharide hemostatic agents are the best materials for stopping bleeding from battlefield trauma, and they are easy to store and transport. However, in the past, such hemostatic agents mostly existed in the form of powders. After the hemostasis was completed, a large amount of powder was left on the wound to adhere, making it difficult to clean the wound later and introducing various safety issues. In addition, when inorganic hemostatic agents, such as zeolite molecular sieves, are used for hemostasis, there is often a problem of huge heat release and burns on the wound surface, which is also one of the difficulties in the application of such hemostatic agents. Studies have shown that conventional inorganic hemostatic agents have poor hemostatic effects on bleeding in patients with coagulation function and cannot successfully stop bleeding. Therefore, the use of inorganic hemostatic agents for hemostasis of bleeding in patients with coagulation function needs further technical improvements.
[0011] The coagulation process is usually considered to be two relatively independent pathways that converge into a common pathway with the generation of thrombin as the end point of the reaction. Thrombin is the catalyst for the hydrolysis of fibrinogen, the ultimate target reaction of the entire coagulation system, and is the most critical protease in the coagulation catalytic reaction. It has a strong ability to hydrolyze fibrinogen. It can be considered that controlling the synthesis of thrombin and increasing its activity are the fundamental ways for the coagulation system to achieve its hemostatic function. The coagulation reaction process is a multi-step waterfall reaction process (i.e., the coagulation waterfall model), which mainly includes the extrinsic coagulation pathway (Extrinsic Pathway) and the intrinsic coagulation pathway (Intrinsic Pathway), as well as the "convergence" of the extrinsic coagulation pathway and the intrinsic coagulation pathway at factor Xa and enter the common coagulation pathway (Common Pathway). Coagulation factor II (Prothrombin) is synthesized by factors Xa, Va, and Ca. 2+The formed prothrombinase complex is activated to thrombin, which cleaves fibrinogen to form fibrinogen monomers, and with the help of coagulation factor XIIIa, crosslinks to form a fibrin network (Crosslinked Fibrin), i.e., thrombus formation. Inorganic hemostatic agents have abundant pores, and their surfaces or inner surfaces of the pores are negatively charged. The intrinsic coagulation pathway (Intrinsic Pathway) begins with the activation of coagulation factor XII by negatively charged inorganic hemostatic agents, and the cascade propagation and activation of coagulation factors such as XI, IX, X, and VIII. Therefore, patients with normal coagulation function can quickly stop bleeding using inorganic hemostatic agents. Severe hemophilia patients use inorganic hemostatic agents to stop bleeding. Since hemophilia patients lack coagulation factors VIII and IX in their blood, the intrinsic coagulation pathway (Intrinsic Pathway) is affected, resulting in poor hemostatic effects of inorganic hemostatic agents and hemostasis failure.
[0012] Quikclot COMBAT GAUZE (combat gauze) developed by Z-Medica in the United States in 2006 has a large amount of tiny kaolin hemostatic agents adhered to the non-woven substrate fibers. Combat gauze is widely used to stop bleeding from war injuries. The non-woven substrate fibers are soaked, dried, cut, vacuum-packed and sterilized in a solution containing kaolin, glycerol and water; the shortcoming of this invention is that when the combat gauze is placed in a solution system (or in contact with blood), the kaolin adhered to the surface of the non-woven fibers will fall off freely. During the process of contacting the wound, the kaolin that falls off may enter the human tissue, which poses a potential clinical risk. In addition, the hemostatic effect is poor for patients with coagulation disorders and they cannot stop bleeding.
[0013] "A hemostatic complex and its preparation method" (CN201810625854.7) invented a preparation method and use of a hemostatic complex. The hemostatic complex of the invention does not require the addition of adhesives. The invention uses a chemical matching coupling between molecular sieves and fibers. The molecular sieves are chemically synthesized. The chemical synthesis reaction conditions of molecular sieves generally require high temperature and high pressure (the temperature in the implementation case is required to be 100 degrees Celsius). The synthesis time of zeolite molecular sieves is long, the production capacity is low, the energy consumption is high, and the high-temperature reaction process causes certain damage to the substrate fiber. The production process produces a large amount of wastewater and waste solids, which is not environmentally friendly, has low efficiency and high cost.
[0014] "A hemostatic fabric containing trypsin and its preparation method" (CN111249516A) This invention still uses the chemical matching coupling between the molecular sieve and the fiber (the temperature in the implementation case is required to be 100 degrees Celsius). The molecular sieve is grown on the fiber surface by chemical synthesis, and then compounded with trypsin to obtain a composite hemostatic material. The synthetic molecular sieve on the fiber surface of this invention still has the disadvantages of harsh reaction conditions, high energy consumption, and long production cycle.
[0015] "A slurry for coating hemostatic gauze and hemostatic gauze prepared using the same" (CN115990284A) uses a suspending agent to prepare the coating slurry, but an adhesive is still added to the slurry. The hemostatic gauze prepared by the invention feels soft, but has a poor hemostatic effect and cannot stop bleeding for patients with coagulation disorders.
[0016] Therefore, it is still a challenging technical problem to manufacture a composite hemostatic fabric that does not use any adhesive, has a low shedding rate of inorganic hemostatic agents loaded on substrate fibers, has a soft feel, is suitable for use in various harsh environments, has high production efficiency, low energy consumption, is environmentally friendly, has high procoagulant activity, and can achieve successful hemostasis by tail amputation of hemophiliac mice (it can also be used by patients with coagulation dysfunction). Summary of the invention
[0017] The object of the present invention is to provide a composite hemostatic fabric and a preparation method thereof, so as to solve the problem in the above background technology that the prior art cannot produce a composite hemostatic fabric that does not use any adhesive, has a mild production process, low energy consumption, has a low shedding rate of inorganic hemostatic agents loaded on substrate fibers, is suitable for use in harsh environments, has high procoagulant activity, and can achieve successful hemostasis by tail amputation in hemophiliac mice (it can also be used by patients with coagulation disorders).
[0018] To achieve the above-mentioned purpose, the present invention provides the following technical solution: a composite hemostatic fabric, which comprises a long-chain polysaccharide solution, glycerol, bovine thrombin, bovine serum albumin and an inorganic hemostatic agent, wherein the content of the long-chain polysaccharide solution ranges from 0.01% to 0.5%, and the mass concentration of glycerol in the solution ranges from 0.5% to 15%.
[0019] As a further embodiment of the present invention, the substrate fiber material includes but is not limited to absorbent cotton gauze, pure cotton non-woven fabric, polyester non-woven fabric, polyester-viscose blended non-woven fabric, polyurethane non-woven fabric, polyurethane sponge sheet, melamine resin sponge sheet, sponge strip and absorbent cotton.
[0020] As a further feature of the present invention, the mixed solution system comprises one or more long-chain polysaccharides or polysaccharides such as xanthan gum, konjac gum, karm gum, guar gum, carrageenan, locust bean gum, etc., the content of the long-chain polysaccharide ranges from 0.01% to 0.5%, the content of long-chain polysaccharide molecules greater than 3 μm is greater than 1%, and preferably the long-chain polysaccharide is a mixture of xanthan gum and konjac gum, and the mass ratio of xanthan gum to konjac gum is 8:2 to 4:6.
[0021] As a further feature of the present invention, the inorganic hemostatic agent is not limited to synthetic molecular sieves or natural inorganic hemostatic agents, such as any one or more of X-type molecular sieve, Y-type molecular sieve, A-type molecular sieve, ZSM-5 molecular sieve, chabazite, β molecular sieve, mordenite, L-type molecular sieve, P-type molecular sieve, AlPO4-5 type molecular sieve, and AlPO4-11 type molecular sieve.
[0022] As a further embodiment of the present invention, the natural inorganic hemostatic agent is an inorganic hemostatic material such as kaolin, clinoptilolite, diaspore, montmorillonite, sodium bentonite, calcium bentonite, polyphosphates and other oxides; before use, the inorganic hemostatic agent is immersed in 5M concentration strontium chloride, calcium chloride and magnesium chloride solution at room temperature for 12 hours once or more to obtain an ion exchange inorganic hemostatic agent.
[0023] A method for preparing a composite hemostatic fabric comprises the following steps:
[0024] S1: stirring a mixed solution of long-chain polysaccharide, glycerol and hemostatic agent at high speed, taking out the substrate fiber from the obtained solution and drying it to prepare a hemostatic fabric for standby use;
[0025] S2: Weigh appropriate amounts of bovine thrombin and bovine serum albumin, and dissolve them in water to prepare a bovine thrombin and bovine serum albumin solution;
[0026] S3: Add an appropriate amount of HEPES and adjust the pH to 6-8 using 0.1 M saline or sodium hydroxide;
[0027] S4: Take the above hemostatic fabric and immerse it in bovine thrombin and bovine serum albumin solution, react for a period of time, take it out and vacuum dry it to a certain degree, cut it, vacuum pack it, and sterilize it to obtain the composite hemostatic fabric.
[0028] As a further feature of the present invention, the inorganic hemostatic agent is kaolin, zeolite or bentonite, with a content range of 0.01% to 20%; the mass concentration of glycerol in the solution is preferably in the range of 1% to 5%; the D50 range of the inorganic hemostatic agent is 1nm to 1000nm, and the D50 range is preferably 20nm to 500nm; preferably, kaolin and zeolite or a mixture of kaolin and bentonite, the mass ratio of kaolin to zeolite is 9:1 to 2:8; when a mixture of kaolin and bentonite is selected, the mass ratio of kaolin to bentonite is 9:1 to 3:7, after the obtained solution is stirred at high speed, the substrate fiber is immersed in the solution or the substrate fiber is passed through the solution under the traction of a mechanical device, and dried at 105°C or in an oven to obtain the hemostatic fabric, and an appropriate amount of bovine thrombin and bovine serum albumin are weighed in a mass ratio of 1:100 to 1:1000, and the mass ratio of bovine thrombin to bovine serum albumin is preferably 1:100 to 1:500, and the concentration of bovine thrombin and bovine serum albumin solution is 1 to 50 g / L; the mass concentration range of glycerol in the solution is 0.5% to 10%. The above-mentioned hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution or the hemostatic fabric is passed through the bovine thrombin and bovine serum albumin solution under the traction of a mechanical device, and then vacuum dried to a certain degree, cut, vacuum packaged, and sterilized to obtain the composite hemostatic fabric.
[0029] As a further feature of the present invention, the mass ratio of the long-chain polysaccharide xanthan gum and konjac gum in the solution system is 7:3 to 4:6, the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, with a concentration of 0.02% to 0.05%, the inorganic hemostatic agent type A molecular sieve D50 is 100 nm, and is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then filtered and cleaned, the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 3%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, the obtained solution is stirred at 4000rpm for 10 minutes, the substrate fiber is immersed in the solution, and dried at 105°C to prepare the hemostatic fabric.
[0030] The mass ratio of bovine thrombin to bovine serum albumin is 1:100-1:500, and the concentration of bovine thrombin and bovine serum albumin solution is 1-10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6-8 using 0.1M saline or sodium hydroxide; the balance is deionized water, the hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, and then vacuum-dried to a certain extent, cut, vacuum-packaged, and sterilized to prepare a composite hemostatic fabric.
[0031] Compared with the prior art, the present invention has the following beneficial effects:
[0032] The solution system of the invention contains one or more long-chain polysaccharides or polysaccharides such as xanthan gum, konjac gum, karm gum, guar gum, carrageenan, locust bean gum, etc., one or more inorganic hemostatic agents, and a certain amount of glycerol. After high-speed stirring, the solution uniformly and stably contains the long-chain polysaccharide, the inorganic hemostatic agent and the glycerol. The substrate fiber is immersed in the solution, a large amount of solution is adsorbed on the surface of the substrate fiber, and after drying, the long-chain polysaccharide and the inorganic hemostatic agent are entangled to form a fishnet structure and are loaded on the surface of the substrate fiber, and water or the solution can quickly enter the inside of the fishnet structure.
[0033] Inorganic hemostatic agents have abundant pores, so some long-chain polysaccharide molecules or side chains will be inserted into the inner surface of the inorganic hemostatic agent pores and at the same time be wrapped by the long-chain polysaccharide. The long-chain polysaccharide and the inorganic hemostatic agent are entangled with each other to form a fishing net structure that is loaded on the fiber surface and dried to form a hemostatic fabric; the hemostatic fabric is immersed in a bovine thrombin and bovine serum albumin solution, or the bovine thrombin and bovine serum albumin solution is sprayed on the hemostatic fabric, and the solution can quickly enter the interior of the fishing net structure. When the bovine thrombin and bovine serum albumin in the solution enter the interior of the fishing net structure and encounter the inorganic hemostatic agent, the side chains of the amino acid residues of the protein (bovine thrombin and bovine serum albumin) are usually positively charged and can interact with the negatively charged surface (Zeta Potential) inorganic hemostatic agent surface or inner surface of the pore attracts each other. The diameter of the inorganic hemostatic agent pore is about 0.4-1.3nm, which generally cannot accommodate complete protein molecules. Therefore, proteins such as bovine thrombin and bovine serum albumin are quickly captured and adsorbed on the surface of the inorganic hemostatic agent or the inner surface of the pore by the inorganic hemostatic agent; because the hemostatic fabric, i.e., the surface of the substrate fiber has been loaded with inorganic hemostatic agent and long-chain polysaccharide, the long-chain polysaccharide and the inorganic hemostatic agent are entangled with each other, and some long-chain polysaccharide molecules or side chains are inserted into the inner surface of the inorganic hemostatic agent pore and are wrapped by the long-chain polysaccharide molecules. When the hemostatic fabric adsorbs bovine thrombin and bovine serum albumin with multi-dimensional space. Due to the strong adsorption of inorganic hemostatic agent and biological protein such as bovine thrombin and bovine serum albumin and the synergistic effect of long-chain polysaccharide, the fishing net structure on the surface of the substrate fiber is more stable, forming a long-chain polysaccharide inorganic-biological protein complex, i.e., a composite hemostatic fabric, the inorganic hemostatic agent is firmly loaded on the surface of the substrate fiber and is not easy to fall off, avoiding the risk of falling off and entering the human body.
[0034] The test results show that the long-chain polysaccharide inorganic-biological protein complex of the fishing net structure has the characteristics of protein corona and excellent procoagulant activity. When blood quickly enters the interior of the fishing net structure composed of the long-chain polysaccharide inorganic-biological protein complex, the high procoagulant protein corona initiates the coagulation reaction, greatly shortening the hemostasis time and reducing blood loss. Due to the high procoagulant protein corona formed on the surface of the substrate fiber with high thrombin activity, compared with the conventional foreign combat gauze COMBATGAUZE, the tail of hemophiliac mice failed to stop bleeding, but the tail of hemophiliac mice using the composite hemostatic fabric can successfully stop bleeding, which greatly broadens the application field of the product. The composite hemostatic fabric not only maintains the softness of the substrate fiber, but can also be used in various complex and harsh environments.
[0035] "A hemostatic complex and its preparation method" (CN201810625854.7) uses in situ chemical synthesis of zeolite molecular sieves on the surface of substrate fibers, which generally requires high temperature and high pressure (the temperature in the implementation case is required to be 100 degrees Celsius). The reaction temperature is high and the energy consumption is high. The production process produces a large amount of waste liquid and waste solid, which is not friendly to the environment. The chemical synthesis of the molecular sieve takes a long time and is costly.
[0036] The early sandwich structure adheres tiny particles, the amount of adhesive used is small and the adhesion effect is poor, and the inorganic hemostatic agent is unstable and easy to fall off; the amount of adhesive used is relatively large and the inorganic hemostatic agent is not easy to fall off, but it is easy to block the molecular sieve pores, which affects its hemostatic performance after the molecular sieve pores are blocked.
[0037] The present invention adopts a two-step method. The first step is to load inorganic hemostatic agents, long-chain polysaccharides and glycerol on the surface of substrate fibers to prepare hemostatic fabrics. The second step is to specifically adsorb and bind bovine thrombin or trypsin and bovine serum albumin to the inorganic hemostatic agents and long-chain polysaccharides loaded on the substrate fibers of the hemostatic fabrics, and to synergistically prepare a structurally stable long-chain polysaccharide inorganic-bioprotein complex, i.e., a composite hemostatic fabric. In the first step, the long-chain polysaccharide and the inorganic hemostatic agent are entangled with each other in the hemostatic fabric with a fishing net structure, thereby avoiding the rapid flocculation and precipitation of the mixed interaction between the inorganic hemostatic agent and the bioprotein. The second step is to prepare the long-chain polysaccharide inorganic-bioprotein composite hemostatic fabric, which creatively utilizes the strong adsorption characteristics of the inorganic hemostatic agent and the protein. The long-chain polysaccharide, the inorganic hemostatic agent and the protein synergistically prepare a high procoagulant activity protein corona protein complex, which can rapidly promote coagulation and reduce blood loss when in contact with blood. The thrombin activity test of the composite hemostatic fabric shows that it has high procoagulant activity. Compared with the failure of conventional foreign combat gauze COMBAT GAUZE to stop bleeding after tail amputation of hemophiliac mice, the composite hemostatic fabric can successfully stop bleeding after tail amputation of hemophiliac mice, which greatly broadens the application field of the product. The low shedding rate of inorganic hemostatic agents greatly reduces the risk of clinical adverse events, and the debridement after hemostasis is simple, and the hemostasis process does not burn the tissue.
[0038] The production process of the invention has mild reaction conditions, low energy consumption, easy continuous production, high production efficiency and low cost; the inorganic hemostatic agent has a low shedding rate to avoid adverse events, the wound debridement after hemostasis is simple, the hemostasis process does not burn tissues, and patients with blood diseases can successfully stop bleeding; the composite hemostatic fabric maintains good enzyme activity after accelerated aging, and is suitable for storage at room temperature. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 It is a schematic diagram of the preparation steps of the structure of the present invention;
[0040] Figure 2 It is a schematic diagram of the coagulation waterfall model of the present invention;
[0041] Figure 3 It is a schematic diagram of the molecular structure of xanthan gum of the present invention;
[0042] Figure 4 It is a schematic diagram of the molecular structure of konjac gum of the present invention;
[0043] Figure 5 It is a schematic diagram of the structure of the composite hemostatic gauze of the present invention. DETAILED DESCRIPTION
[0044] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0045] See also Figures 1 to 5 , an embodiment provided by the present invention:
[0046] A composite hemostatic fabric, implementation 1:
[0047] The solution system of the invention contains one or more long-chain polysaccharides (or polysaccharides) such as xanthan gum, konjac gum, kam gum, guar gum, carrageenan, locust bean gum, etc., the molecular length of the long-chain polysaccharide is preferably above 3 μm and the content is above 1%, the content of the long-chain polysaccharide ranges from 0.01% to 0.5%, and the preferred range is 0.02% to 0.05%; the mass concentration of glycerol in the solution ranges from 0.5% to 15%; the solution system contains one or more micro inorganic hemostatic agents such as kaolin, zeolite, and bentonite, the inorganic hemostatic agent is not limited to natural or synthetic, the D50 range of the inorganic hemostatic agent is 1nm to 500nm, and the solid content ranges from 0.01% to 20%; after the obtained solution is stirred at high speed, the substrate fiber is taken out from the solution and dried to prepare the hemostatic fabric for standby use.
[0048] Weigh appropriate amount of bovine thrombin and bovine serum albumin in a mass ratio of (1:100) to (1:1000), dissolve them in water to prepare a bovine thrombin and bovine serum albumin solution, the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 50 g / L; the mass concentration of glycerol in the solution ranges from 0.5% to 10%; add appropriate amount of HEPES, and use 0.1M saline or sodium hydroxide to adjust the pH to 6 to 8. Take the above hemostatic fabric and immerse it in the bovine thrombin and bovine serum albumin solution, react for a period of time, take it out, vacuum dry it to a certain degree, cut it, vacuum pack it, and sterilize it to obtain the composite hemostatic fabric.
[0049] The solution system comprises one or more long-chain polysaccharides (or polysaccharides) such as xanthan gum, konjac gum, karm gum, guar gum, carrageenan, locust bean gum, etc., preferably, the long-chain polysaccharide molecules are longer than 3 μm and the content is greater than 1%; preferably, the long-chain polysaccharide is a mixture of xanthan gum and konjac gum, and the mass ratio of xanthan gum to konjac gum is (8:2) to (4:6).
[0050] The inorganic hemostatic agent is not limited to natural or synthetic, one or more, with a content range of 0.01% to 20%; the mass concentration range of glycerol in the solution is: 0.5% to 15%, preferably 1% to 5%; the D50 range of the inorganic hemostatic agent is 1nm to 1000nm, and the D50 range is preferably 20nm to 500nm; kaolin and zeolite or kaolin and bentonite mixture is preferred, and the mass ratio of kaolin and zeolite is (9:1) to (2:8); when kaolin and bentonite mixture is selected, the mass ratio of kaolin and bentonite is (9:1) to (3:7); after the obtained solution is stirred at high speed, the substrate fiber is immersed in the solution or the substrate fiber is passed through the solution under the traction of a mechanical device, and the hemostatic fabric is obtained by drying at 105°C or drying in an oven.
[0051] Inorganic hemostatic agents are not limited to synthetic molecular sieves or natural inorganic hemostatic agents, such as synthetic molecular sieves, such as any one or more of X-type molecular sieve, Y-type molecular sieve, A-type molecular sieve, ZSM-5 molecular sieve, chabazite, β molecular sieve, mordenite, L-type molecular sieve, P-type molecular sieve, AlPO4-5 type molecular sieve, AlPO4-11 type molecular sieve; natural inorganic hemostatic agents such as kaolin, clinoptilolite, diaspore, montmorillonite, sodium bentonite, calcium bentonite, polyphosphates and other oxides and other inorganic hemostatic materials; before use, the inorganic hemostatic agent is immersed in 5M concentration strontium chloride, calcium chloride and magnesium chloride solution at room temperature for 12 hours once or more to obtain an ion exchange inorganic hemostatic agent.
[0052] Weigh appropriate amounts of bovine thrombin and bovine serum albumin in a mass ratio of (1:100) to (1:1000), preferably (1:100) to (1:500), the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 50 g / L, and the mass concentration of glycerol in the solution ranges from 0.5% to 10%. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution or the hemostatic fabric is passed through the bovine thrombin and bovine serum albumin solution under the traction of a mechanical device, and then vacuum-dried to a certain degree, cut, vacuum-packaged, and sterilized to obtain the composite hemostatic fabric.
[0053] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution and immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then filtered and cleaned, the inorganic hemostatic agent calcium-based type A molecular sieve mass concentration is 3%; the mass concentration of glycerol in the solution ranges from 1% to 5%; the balance is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is (1:100) to (1:500), and the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, and then vacuum-dried to a certain degree, cut, vacuum-packaged, and sterilized to prepare a composite hemostatic fabric.
[0054] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.13 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 0.14%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.16%. The in vitro coagulation time is 45 s, and the thrombin activity of the composite hemostatic fabric is 1.45 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0055] Implementation 2:
[0056] The mass ratio of the long-chain polysaccharide xanthan gum and konjac gum in the solution system is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 3%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000 rpm for 10 minutes. The substrate fiber is immersed in the solution, dried to a certain degree at 105°C, cut, vacuum packaged, and sterilized to prepare the hemostatic fabric.
[0057] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.35 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 84.21%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 88.26%. The in vitro coagulation time is about 124 s. The thrombin activity of the composite hemostatic fabric is 0 NIH U. The hemostatic fabric failed to stop bleeding when the hemophiliac mice were tail-cut and the mice all died.
[0058] The difference between Example 2 and Example 1 is that the prepared hemostatic fabric is not immersed in bovine thrombin and bovine serum albumin solution. The composite hemostatic fabric cannot form a high thromboplastin active substance, so the hemophilia mice tail amputation using the composite hemostatic fabric failed to stop bleeding, and the mice all died.
[0059] Implementation 3:
[0060] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), and the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, and the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 2%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The concentration of the bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the balance is deionized water. The hemostatic fabric is immersed in a bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed and sterilized to prepare a composite hemostatic fabric.
[0061] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.41 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 0.18%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.20%. The in vitro coagulation time is 119 s. The thrombin activity of the composite hemostatic fabric is 0 NIH U. The composite hemostatic fabric failed to stop bleeding when the hemophiliac mice were tail-amputated, and all the mice died.
[0062] The difference between Example 3 and Example 1 is that the prepared composite hemostatic fabric does not contain bovine thrombin when immersed in bovine serum albumin solution. The composite hemostatic fabric lacks bovine thrombin and cannot form high-promoting thromboplastin active substances. Therefore, the composite hemostatic fabric fails to stop bleeding when the hemophilia mice are tail-amputated and the mice all die.
[0063] Implementation 4:
[0064] In this embodiment, the mass ratio of the long-chain polysaccharide xanthan gum and konjac gum in the solution system is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the mass ratio of the inorganic hemostatic agent kaolin and the Y-type molecular sieve is (9:1) to (6:4), and the D50 is 500nm and 400nm respectively. The substrate is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned. The mass concentration of the inorganic hemostatic agent calcium-kaolin and calcium-Y-type molecular sieve is 2%; the mass concentration of glycerol in the solution ranges from 1% to 5%; the balance is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is (1:100) to (1:500), and the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0065] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.43 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 0.12%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.13%. The in vitro coagulation time is 41 s, and the thrombin activity of the composite hemostatic fabric is 1.52 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0066] The difference between Example 4 and Example 1 is that two different inorganic calcium-based hemostatic agents are used.
[0067] Implementation 5:
[0068] In this embodiment, the mass ratio of the long-chain polysaccharide xanthan gum and konjac gum in the solution system is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the mass ratio of the inorganic hemostatic agent kaolin and the Y-type molecular sieve is (9:1) to (6:4), D50 is 500nm and 400nm respectively, and the mass concentration of the inorganic hemostatic agent kaolin and the Y-type molecular sieve is 2%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is (1:100) to (1:500), and the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0069] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.60 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 1.01%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 1.26%. The in vitro coagulation time is 76 s, and the thrombin activity of the composite hemostatic fabric is 1.13 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0070] The difference between Example 5 and Example 1 is that the inorganic hemostatic agent is used directly without ion exchange. The test results show that the inorganic hemostatic agent exchanged with calcium, magnesium and strontium is more conducive to the adsorption of bovine thrombin, reducing the in vitro coagulation time and improving the thrombin activity.
[0071] Implementation 6:
[0072] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02 to 0.05%; the mass ratio of the inorganic hemostatic agent kaolin and bentonite is (9:1) to (6:4), and the D50 is 2 μm and 3 μm respectively. The solution is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned. The mass concentration of the inorganic hemostatic agent calcium-A kaolin and calcium-bentonite is 2%; the mass concentration of glycerol in the solution ranges from 1% to 5%; the balance is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is (1:100) to (1:500), and the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0073] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.51 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 4.24%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 5.26%. The in vitro coagulation time is 79 s, and the thrombin activity of the composite hemostatic fabric is 1.46 NIH U. The composite hemostatic fabric can still successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0074] The difference between Example 6 and Example 1 is that the inorganic hemostatic agents kaolin and bentonite D50 are 2 μm and 3 μm respectively, which is larger than the inorganic hemostatic agent type A molecular sieve D50 of 100 nm in size in Example 1. The larger particle size of the inorganic hemostatic agent increases the difficulty of wrapping the long-chain polysaccharide molecules, so the shedding rate in water is relatively increased.
[0075] Implementation 7:
[0076] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin and bovine serum albumin is (1:100) to (1:500), and the concentration of bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; add an appropriate amount of HEPES, and use 0.1M saline or sodium hydroxide to adjust the pH to 6 to 8; the balance is deionized water. The above-mentioned hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, vacuum dried to a certain extent, cut, vacuum packaged, and sterilized to prepare a composite hemostatic fabric.
[0077] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.37 cm, the in vitro coagulation time is 354 s, the hemostatic fabric is not loaded with inorganic hemostatic agents and does not fall off, the thrombin activity of the composite hemostatic fabric is 0.03 NIH U, and the composite hemostatic fabric fails to stop bleeding when the tails of hemophilia mice are docked, and most of the mice die, with a survival rate of 33.3%.
[0078] The difference between Example 7 and Example 1 is that no inorganic hemostatic agent is added to the solution in the first step. Experiments show that part of the bovine thrombin is inactivated and does not have the coagulant performance. Therefore, the in vitro coagulation time is longer and the thrombin activity is lower.
[0079] Implementation 8:
[0080] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution and immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, the inorganic hemostatic agent calcium-based type A molecular sieve mass concentration is 2%; the mass concentration range of glycerol in the solution is: 1% to 5%; the mass of the binder component in the polymer colloidal emulsion added to the solution accounts for 0.3% of the total content of the solution, and the remainder is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution, dried to a certain extent at 105°C, cut, vacuum packaged, and sterilized to prepare a hemostatic fabric.
[0081] The hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 3.56 cm, the in vitro coagulation time is 164 s, and the shedding rate of the inorganic hemostatic agent in water is 5.29% under the condition of ultrasonic cleaning for 1 min. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 7.26%. The thrombin activity of the hemostatic fabric is 0 NIH U. However, tail amputation of hemophiliac mice failed to stop bleeding, and all the mice died.
[0082] The difference between Example 8 and Example 1 is that an appropriate amount of adhesive is added to the solution in the first step, and the solution is not immersed in bovine thrombin and bovine serum albumin solution in the second step. Therefore, the bovine thrombin activity of the hemostatic fabric is 0 NIH U, and the longer in vitro coagulation time may be due to the adhesive sealing the inorganic hemostatic agent.
[0083] Implementation 9:
[0084] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution and immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, the inorganic hemostatic agent calcium-based type A molecular sieve mass concentration is 2%; the mass concentration range of glycerol in the solution is: 1% to 5%; the mass of the binder component in the polymer colloidal emulsion added to the solution accounts for 5% of the total content of the solution, and the remainder is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution, dried to a certain extent at 105°C, cut, vacuum packaged, and sterilized to prepare a hemostatic fabric.
[0085] The hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 6.33 cm, the in vitro coagulation time is 215 s, and the shedding rate of the inorganic hemostatic agent in water is 0.28% under the condition of ultrasonic cleaning for 1 min. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.34%. The thrombin activity of the hemostatic fabric is 0 NIH U. However, tail amputation of hemophiliac mice failed to stop bleeding, and all the mice died.
[0086] The difference between Example 9 and Example 8 is that more adhesive is added. The increase in the adhesive content effectively reduces the ultrasonic shedding rate. The increase in the adhesive content further prolongs the in vitro coagulation time.
[0087] Implementation 10:
[0088] In this embodiment, the concentration of long-chain polysaccharide xanthan gum in the solution system is 0.02% to 0.05%; the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, the inorganic hemostatic agent calcium-based type A molecular sieve mass concentration is 2%; the mass concentration of glycerol in the solution ranges from 1% to 5%; the balance is deionized water, and the resulting solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is (1:100) to (1:500), and the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0089] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.37 cm, the in vitro coagulation time is 115 s, and the shedding rate of the inorganic hemostatic agent in water is 1.71% under the condition of ultrasonic cleaning for 1 min. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 1.86%. The thrombin activity of the composite hemostatic fabric is 1.42 NIH U. Tail amputation of hemophiliac mice can successfully stop bleeding, and the survival rate of mice is 100%.
[0090] The difference between Example 10 and Example 1 is that only one long-chain polysaccharide xanthan gum is added to the solution in the first step. Experiments show that the long-chain polysaccharide has a better effect when used in combination, and the long-chain polysaccharide can appropriately reduce the shedding of inorganic hemostatic agents when used in combination.
[0091] Implementation 11:
[0092] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, the inorganic hemostatic agent calcium-based type A molecular sieve mass concentration is 2%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin and bovine serum albumin is (1:100) to (1:500), and the concentration of bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution for 20 seconds, taken out, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0093] The difference between Example 11 and Example 1 is that the hemostatic fabric is immersed in the solution for 20 seconds in the second step.
[0094] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.55 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 0.18%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.22%. The in vitro coagulation time is 47 s, and the thrombin activity of the composite hemostatic fabric is 1.39 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0095] Implementation 12:
[0096] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, and a concentration of 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, the inorganic hemostatic agent calcium-based type A molecular sieve mass concentration is 2%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin and bovine serum albumin is (1:100) to (1:500), and the concentration of bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution for 10 seconds, taken out, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0097] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.36 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of inorganic hemostatic agent in water is 0.21%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of inorganic hemostatic agent in water is 0.26%. The external coagulation time is 49 s. The thrombin activity of the composite hemostatic fabric is 1.38 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the tail of hemophiliac mice is cut off, and the survival rate of mice is 100%. The test results of this embodiment show that the present invention is suitable for continuous industrial production.
[0098] The difference between Example 12 and Example 11 is that the second step of the hemostatic fabric is immersed in the solution for 10 seconds. The difference between the two is unlikely because the immersion time is shorter than the vacuum drying time, so the immersion time has little effect.
[0099] Implementation 13:
[0100] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), and the long-chain polysaccharide is preferably 1% or more with a molecular length of 5 μm or more, and the concentration is 0.01% to 0.03%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, and the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 3%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is (1:100) to (1:500), and the concentration of the bovine thrombin and bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0101] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.01 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 0.14%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.15%. The in vitro coagulation time is 46 s, and the thrombin activity of the composite hemostatic fabric is 1.44 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0102] The difference between Example 13 and Example 1 is that the content of the long-chain polysaccharide molecules is different.
[0103] Implementation 14:
[0104] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), and the long-chain polysaccharide is preferably 1% or more with a molecular length of 3 μm or more, and the concentration is 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, and the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 3%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The mass ratio of trypsin to bovine serum albumin is (1:100) to (1:500), and the concentration of trypsin to bovine serum albumin solution is 1 to 10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the remainder is deionized water. The hemostatic fabric is immersed in the trypsin and bovine serum albumin solution, vacuum dried to a certain degree, cut, vacuum packed, and sterilized to prepare a composite hemostatic fabric.
[0105] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.53 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 0.15%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 0.17%. The in vitro coagulation time is 50 s, and the thrombin activity of the composite hemostatic fabric is 1.38 NIH U. The composite hemostatic fabric is used to successfully stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 100%.
[0106] The difference between Example 14 and Example 1 is that trypsin is selected. The test results show that trypsin and bovine thrombin have no obvious effect on the thrombin activity of the composite hemostatic fabric.
[0107] Implementation 15:
[0108] In this embodiment, the mass ratio of the solution system long-chain polysaccharide xanthan gum and konjac gum is (7:3) to (4:6), and the long-chain polysaccharide is preferably 1% or more with a molecular length of 3 μm or more, and the concentration is 0.02% to 0.05%; the inorganic hemostatic agent type A molecular sieve (D50 is 100 nm) is immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours, separated from the solution, and then immersed in a 5M concentration calcium chloride solution at room temperature for 12 hours twice, and then cleaned, and the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 3%; the mass concentration range of glycerol in the solution is: 1% to 5%; the balance is deionized water, and the obtained solution is stirred at 4000rpm for 10 minutes. The substrate fiber is immersed in the solution and dried at 105°C to prepare a hemostatic fabric. The concentration of the trypsin solution is 0.1 to 5 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6 to 8 using 0.1M saline or sodium hydroxide; the balance is deionized water. The hemostatic fabric is immersed in a trypsin solution, vacuum dried to a certain degree, cut, vacuum packed and sterilized to prepare a composite hemostatic fabric.
[0109] The composite hemostatic fabric prepared in this embodiment has a soft feel and is suitable for hemostasis of various complex wounds. The average bending length is 2.51 cm. Under the condition of ultrasonic cleaning for 1 min, the shedding rate of the inorganic hemostatic agent in water is 6.34%. Under the condition of ultrasonic cleaning for 5 min, the shedding rate of the inorganic hemostatic agent in water is 7.31%. The in vitro coagulation time is 98 s. The thrombin activity of the composite hemostatic fabric is 0.04 NIH U. The composite hemostatic fabric fails to stop bleeding when the hemophiliac mice are tail-amputated, and the survival rate of the mice is 33.3%.
[0110] The difference between Example 15 and Example 14 is that bovine serum albumin is not added to the protein solution. The bovine thrombin activity of the composite hemostatic fabric in this example is 0.04 NIH U. The test results show that bovine thrombin (or trypsin) needs to be used in combination with bovine serum albumin to ensure its thrombin activity.
[0111] Implementation 16:
[0112] Commercial combat gauze (Combat Gauze) is an inorganic hemostatic material (clay, kaolin) attached to the fiber surface. It is soft to the touch and suitable for hemostasis of various complex wounds. The average bending length is 2.04 cm. Under the condition of ultrasonic cleaning for 1 minute, the detachment rate of clay on the gauze fiber is 91.2%; under the condition of ultrasonic cleaning for 5 minutes, the detachment rate of clay on the gauze fiber is 96.8%. The in vitro coagulation time is 117 seconds, and the thrombin activity of the composite hemostatic fabric is 0 NIH U. The composite hemostatic fabric failed to stop bleeding when the tails of hemophiliac mice were cut off, and all the mice died.
[0113] The performance test performed by the present invention is as follows:
[0114] Sodium citrate (109mmol / L) solution and fresh porcine whole blood are mixed at a volume ratio of 1:9 and shaken for use; take an appropriate amount (XmL) of 0.2M calcium chloride solution and add it to a 5mL centrifuge tube containing a certain amount of sodium citrate anticoagulated porcine whole blood, and adjust the blood coagulation time to 8-10min, which is the natural coagulation time. Take an appropriate amount (XmL) of 0.2M calcium chloride solution and a certain amount of composite hemostatic fabric in a 5mL centrifuge tube, add a certain amount of sodium citrate anticoagulated porcine whole blood, shaken, start timing and record the blood coagulation time, which is the in vitro coagulation time.
[0115] Drop rate in water:
[0116] A certain amount of composite hemostatic fabric is soaked in water, and then ultrasonicated for 1 minute and 5 minutes respectively. The composite hemostatic fabric or hemostatic gauze is picked up and hung above the soaking liquid until no liquid drips. Then, the soaking liquid is filtered to collect the fallen particles, dried and weighed, and the shedding rate is calculated. This indicator evaluates how many particles may enter the liquid when the product comes into contact with the liquid.
[0117] The softness of the fabric is characterized by the bending length index of the fabric:
[0118] The bending length of a fabric refers to the length of a fabric strip when one end of the fabric is suspended in the air and the fabric strip is bent downward to 7.1° under the action of its own weight. GB / T18318.1-2009 "Determination of the Bending Properties of Textiles Part 1: Inclined Plane Method".
[0119] In this application, the testing method for bending length is in accordance with GB / T 18318.1-2009 “Determination of bending properties of textiles Part 1: Inclined plane method”.
[0120] The average bending length is obtained by dividing the sum of the warp bending length and the weft bending length by 2.
[0121] The calculation method of the average bending length refers to the data processing method adopted in HG / T5254-2017 "Determination of the Stiffening Effect of Textile Dyeing and Finishing Auxiliary Agents".
[0122] The smaller the bending length value obtained by the test, the better the softness of the fabric, that is, the worse the stiffness of the fabric. The larger the bending length, the less soft the fabric, that is, the higher the stiffness of the fabric.
[0123] The sample was cut into sample strips with a width of 2 cm and stored at room temperature for 20 hours in an environment with a humidity of 60-70%. The average bending length was tested on a 702 stiffness tester according to the test method of the national standard GB / T18318.1-2009.
[0124] Tail docking time for hemophiliac mice to stop bleeding:
[0125] The tail of the hemophilia mouse was cut off 1 cm, and the tail was bandaged with 4 layers of composite hemostatic fabric. When blood stopped oozing out of the composite hemostatic fabric, the bleeding stopped. The hemostasis time was recorded. Each sample was tested three times in parallel to calculate the average value. The survival status of the hemophilia mice within 8 hours was recorded and the survival rate was calculated.
[0126] Thrombin activity test by chromogenic substrate method (thrombin activity):
[0127] Thrombin undergoes an enzymatic hydrolysis reaction with its specific chromogenic substrate (CS-01 (38), HYPHEN BioMed), which releases a substance with a chromogenic group (pNA). The absorbance of the chromogenic substance at 405 nm is positively correlated with the activity of bovine thrombin.
[0128] A certain amount of composite hemostatic fabric sample, 1 mL of thrombin chromogenic substrate (4 mg / mL) and 1 mL of HEPES buffer (20 mM HEPES, 150 mM NaCl, pH 7.4) were mixed thoroughly and evenly in a centrifuge tube, shaken for 2 min at 37°C, and 500 μL of glacial acetic acid was added to terminate the reaction. Centrifugation was performed to obtain the supernatant, and the process was repeated twice. Finally, the absorbance at 405 nm was measured with a total volume of 2 mL of supernatant.
[0129] Prepare standard bovine thrombin solutions of different concentrations, measure the absorbance and draw a standard curve. Calculate the thrombin activity in the sample according to the standard curve. Composite hemostatic fabric stability method: Composite hemostatic fabric is cut into aluminum foil bags and sealed for vacuum packaging. After sterilization, it is placed in a 60℃ oven for accelerated aging for 97 days (60℃*97D), which is equivalent to 3 years at room temperature.
[0130] Table 1 below is a table of composite hemostatic fabric performance:
[0131]
[0132]
[0133] Table 2 below is a test table of the hemostatic performance of the composite hemostatic fabric:
[0134]
[0135]
[0136] Table 3 below shows: Zeta potential of inorganic hemostatic agents
[0137] Serial number name ZetaPotential / mv 1 talc -16.67 2 Clinoptilolite -21.51 3 Diaspore -15.39 4 Magnesium-rich montmorillonite -16.87 5 Calcium Bentonite -14.12 6 Mordenite -14.24 7 diatomite -16.31 8 Calcium montmorillonite -17.56 9 Ca-Y molecular sieve -22.48 10 Ca-A molecular sieve -21.64 11 X-type molecular sieve -19.95 12 ZSM-5 molecular sieve -18.27 13 chabazite -16.98 14 Beta molecular sieve -17.39 15 L-type molecular sieve -19.02 16 P-type molecular sieve -20.06 17 Kaolin -22.34
[0138] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.
Claims
1. A composite hemostatic fabric, characterized in that: The composite hemostatic fabric comprises long-chain polysaccharide solution, glycerol, bovine thrombin, bovine serum albumin and inorganic hemostatic agent, wherein the content of the long-chain polysaccharide solution ranges from 0.01% to 0.5%, and the mass concentration of glycerol in the solution ranges from 0.5% to 15%.
2. The composite hemostatic fabric according to claim 1, characterized in that: The substrate fiber material includes but is not limited to absorbent cotton gauze, pure cotton non-woven fabric, polyester non-woven fabric, polyester-viscose fiber blended non-woven fabric, polyurethane non-woven fabric, polyurethane sponge sheet, melamine resin sponge sheet, sponge strip and absorbent cotton.
3. The composite hemostatic fabric according to claim 2, characterized in that: The mixed solution system comprises one or more long-chain polysaccharides or polysaccharides such as xanthan gum, konjac gum, karm gum, guar gum, carrageenan, locust bean gum, etc. The content of the long-chain polysaccharide is in the range of 0.01% to 0.5%, and the content of the long-chain polysaccharide molecules greater than 3 μm is greater than 1%. Preferably, the long-chain polysaccharide is a mixture of xanthan gum and konjac gum, and the mass ratio of xanthan gum to konjac gum is 8:2 to 4:
6.
4. The composite hemostatic fabric according to claim 3, characterized in that: The inorganic hemostatic agent is not limited to synthetic molecular sieves or natural inorganic hemostatic agents, such as any one or more of X-type molecular sieve, Y-type molecular sieve, A-type molecular sieve, ZSM-5 molecular sieve, chabazite, β molecular sieve, mordenite, L-type molecular sieve, P-type molecular sieve, AlPO4-5 type molecular sieve, and AlPO4-11 type molecular sieve.
5. The composite hemostatic fabric according to claim 4, characterized in that: The natural inorganic hemostatic agent includes inorganic hemostatic materials such as kaolin, clinoptilolite, diaspore, montmorillonite, sodium bentonite, calcium bentonite, polyphosphates and other oxides; before use, the inorganic hemostatic agent is immersed in 5M concentration strontium chloride, calcium chloride and magnesium chloride solution at room temperature for 12 hours once or multiple times to obtain an ion exchange inorganic hemostatic agent.
6. A method for preparing a composite hemostatic fabric, characterized in that: The following steps are involved: S1: stirring a mixed solution of long-chain polysaccharide, glycerol and inorganic hemostatic agent at high speed, taking out the substrate fiber from the obtained solution and drying it to prepare a hemostatic fabric for standby use; S2: Weigh bovine thrombin and bovine serum albumin, and dissolve them in water to prepare a bovine thrombin and bovine serum albumin solution; S3: Add an appropriate amount of HEPES and adjust the pH to 6-8 using 0.1 M saline or sodium hydroxide; S4: Take the above hemostatic fabric and immerse it in bovine thrombin and bovine serum albumin solution, react for a period of time, take it out and vacuum dry it to a certain degree, cut it, vacuum pack it, and sterilize it to obtain the composite hemostatic fabric.
7. The method for preparing a composite hemostatic fabric according to claim 5, characterized in that: The inorganic hemostatic agent is kaolin, zeolite or bentonite, and the content range is 0.01% to 20%; the mass concentration range of glycerol in the solution is preferably 1% to 5%; the D50 range of the inorganic hemostatic agent is 1nm to 1000nm, and the D50 range is preferably 20nm to 500nm; kaolin and zeolite or a mixture of kaolin and bentonite is preferred, and the mass ratio of kaolin to zeolite is 9:1 to 2:8; when a mixture of kaolin and bentonite is selected, the mass ratio of kaolin to bentonite is 9:1 to 3:7, and the obtained After the solution is stirred at high speed, the substrate fiber is immersed in the solution or the substrate fiber is passed through the solution under the traction of a mechanical device, and then dried at 105°C or in an oven to obtain the hemostatic fabric. An appropriate amount of bovine thrombin and bovine serum albumin are weighed in a mass ratio of 1:100 to 1:1000, and the mass ratio of bovine thrombin to bovine serum albumin is preferably 1:100 to 1:
500. The concentration of the bovine thrombin and bovine serum albumin solution is 1 to 50 g / L; the mass concentration of glycerol in the solution ranges from 0.5% to 10%. The above-mentioned hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution or the hemostatic fabric is passed through the bovine thrombin and bovine serum albumin solution under the traction of a mechanical device, and then vacuum dried to a certain degree, cut, vacuum packaged, and sterilized to obtain the composite hemostatic fabric.
8. The method for preparing a composite hemostatic fabric according to claim 6, characterized in that: The solution system comprises a mass ratio of long-chain polysaccharide xanthan gum to konjac gum of 7:3 to 4:6, the long-chain polysaccharide preferably has a molecular length of more than 3 μm and a content of more than 1%, with a concentration of 0.02% to 0.05%, an inorganic hemostatic agent type A molecular sieve D50 of 100 nm, is immersed in a 5M calcium chloride solution at room temperature for 12 hours, is separated from the solution, is immersed in a 5M calcium chloride solution at room temperature for 12 hours for two times, and is then filtered and cleaned, the mass concentration of the inorganic hemostatic agent calcium-based type A molecular sieve is 3%, the mass concentration of glycerol in the solution ranges from 1% to 5%, and the balance is deionized water, the obtained solution is stirred at 4000 rpm for 10 minutes, the substrate fiber is immersed in the solution, and is dried at 105° C. to prepare the hemostatic fabric. The mass ratio of bovine thrombin to bovine serum albumin is 1:100-1:500, and the concentration of bovine thrombin and bovine serum albumin solution is 1-10 g / L; an appropriate amount of HEPES is added, and the pH is adjusted to 6-8 using 0.1M saline or sodium hydroxide; the balance is deionized water, the hemostatic fabric is immersed in the bovine thrombin and bovine serum albumin solution, and then vacuum-dried to a certain extent, cut, vacuum-packaged, and sterilized to prepare a composite hemostatic fabric.
Citation Information
Patent Citations
Non-woven hemostatic gauze as well as preparation method and application thereof
CN114748670A
Slurry for coating hemostatic gauze and hemostatic gauze prepared from slurry
CN115990284A
Hemostatic compositions and methods for controlling bleeding
US20030175327A1
Hemostatic materials
US20060051340A1
Cited By
Multilayer hemostatic agent based on carrageenan and a method for its production
RU2864324C1
